Glibenclamide is an oral hypoglycemic agent used to treat type 2 diabetes mellitus. It works by stimulating insulin secretion from the pancreas, thereby lowering blood glucose levels. Glibenclamide is clinically significant for managing diabetes and preventing complications associated with high blood sugar. In summary, glibenclamide is essential for controlling blood sugar levels in diabetic patients.
Glibenclamide binds to sulfonylurea receptors on pancreatic beta cells, leading to increased insulin release and subsequent reduction in blood glucose levels.













